Barchart.com
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
0.4150 x 99 0.4390 x 99
Post-market by (Cboe BZX)
0.4206 -0.0298 (-6.62%) 04/24/25 [NASDAQ]
0.4150 x 99 0.4390 x 99
Post-market 0.4300 +0.0094 (+2.23%) 17:20 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference GlobeNewswire - Wed Apr 2, 5:59AM CDT

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire - Thu Mar 13, 3:05PM CDT

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference GlobeNewswire - Mon Feb 24, 5:59AM CST

GBIO : 0.4206 (-6.62%)
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases GlobeNewswire - Mon Jan 6, 3:30PM CST

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 2024

GBIO : 0.4206 (-6.62%)
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress GlobeNewswire - Tue Oct 22, 2024

GBIO : 0.4206 (-6.62%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings Barchart - Mon Oct 23, 2023

December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...

GOOGL : 159.28 (+2.53%)
CVX : 139.07 (+1.75%)
MRK : 79.84 (+1.40%)
NQZ23 : 16,530.23s (-0.07%)
MSFT : 387.30 (+3.45%)
KNX : 40.36 (+1.94%)
MA : 535.46 (+1.03%)
V : 335.71 (+0.40%)
HARP : 23.01 (+0.09%)
WBA : 11.03 (+0.36%)
PINS : 25.75 (+0.55%)
ESZ23 : 4,694.27s (-0.58%)
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines ACCESS Newswire - Thu Mar 23, 2023

Collaboration will extend the applications of each company's platform through discovery and development of novel lipid nanoparticles using Generation Bio's proprietary stealth cell-targeted lipid nanoparticle...

GBIO : 0.4206 (-6.62%)
MRNA : 27.39 (+3.20%)
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results Globe Newswire - Thu Aug 4, 2022

Cash balance of $312.2M expected to fund operations into 2025...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference Globe Newswire - Tue Aug 2, 2022

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors Globe Newswire - Mon Jul 18, 2022

CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the 2022 Jefferies Healthcare Conference Globe Newswire - Thu Jun 2, 2022

CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results Globe Newswire - Thu May 5, 2022

Company continues to optimize cell-targeted lipid nanoparticle (ctLNP) delivery system for nonviral genetic medicine applications in liver, retina and...

GBIO : 0.4206 (-6.62%)
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference Globe Newswire - Tue Apr 5, 2022

CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference Globe Newswire - Wed Mar 2, 2022

CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results Globe Newswire - Thu Feb 24, 2022

Well-capitalized with $375.1 million at the end of 2021, funding planned operations into 2024...

GBIO : 0.4206 (-6.62%)
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer Globe Newswire - Thu Feb 10, 2022

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference Globe Newswire - Wed Jan 5, 2022

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
SHAREHOLDER ALERT: Robbins LLP Investigates Generation Bio Co. (GBIO) on Behalf of Shareholders Business Wire - Tue Dec 28, 2021

Shareholder rights law firm Robbins LLP is investigating Generation Bio Co. (NASDAQ: GBIO) to determine whether certain Generation Bio officers and directors violated the Securities Exchange Act of 1934...

GBIO : 0.4206 (-6.62%)
Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program Globe Newswire - Tue Dec 14, 2021

Innovations in closed-ended DNA (ceDNA) and cell-targeted lipid nanoparticle (ctLNP) production processes generated peak mean of 205% normal human factor...

GBIO : 0.4206 (-6.62%)

Barchart Exclusives

Grain Rally Mystery: Why Are Soybeans, Corn, and Wheat Bucking the Trend? Barchart - 1 hour ago
In an interview on AgWeb's Markets Now, Darin Newsom of Barchart discussed the surprising grain market rally led by soybeans despite negative China trade news, a potential corrective bounce in corn with weak basis, and a likely bear trap in wheat, while also touching on the bullish cattle market's connection to equities and a potential shift out of stocks into safer assets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot